tiprankstipranks
Trending News
More News >
Basilea Pharmaceutica (CH:BSLN)
:BSLN
Switzerland Market

Basilea Pharmaceutica (BSLN) Technical Analysis

Compare
7 Followers

Summary of all the Indicators

Overall Consensus
Buy
15Bullish
2Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Basilea Pharmaceutica’s (BSLN) Moving Averages Convergence Divergence (MACD) indicator is 1.17, suggesting Basilea Pharmaceutica is a Sell.
Basilea Pharmaceutica’s (BSLN) 20-Day exponential moving average is 56.26, while Basilea Pharmaceutica’s (BSLN) share price is CHF58.1, making it a Buy.
Basilea Pharmaceutica’s (BSLN) 50-Day exponential moving average is 54.19, while Basilea Pharmaceutica’s (BSLN) share price is CHF58.1, making it a Buy.

Basilea Pharmaceutica (BSLN) Pivot Points

Feb 14, 2026, 12:38 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
56.60
57.10
57.50
58.00
58.40
58.90
59.30
Fibonacci
57.10
57.44
57.66
58.00
58.34
58.56
58.90
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Basilea Pharmaceutica (BSLN) Moving Averages

Feb 14, 2026, 12:38 PM
Period
Simple
Exponential
MA5
57.88Buy
57.82Buy
MA10
56.94Buy
57.19Buy
MA20
55.70Buy
56.26Buy
MA50
54.15Buy
54.19Buy
MA100
50.78Buy
52.12Buy
MA200
49.64Buy
50.09Buy
Basilea Pharmaceutica’s (BSLN) 10-Day exponential moving average is 57.19, while Basilea Pharmaceutica’s (BSLN) share price is CHF58.1, making it a Buy.
Basilea Pharmaceutica’s (BSLN) 100-Day exponential moving average is 52.12, while Basilea Pharmaceutica’s (BSLN) share price is CHF58.1, making it a Buy.
Basilea Pharmaceutica’s (BSLN) stock price is CHF58.1 and Basilea Pharmaceutica’s (BSLN) 50-day simple moving average is 54.15, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) stock price is CHF58.1 and Basilea Pharmaceutica’s (BSLN) 100-day simple moving average is 50.78, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) stock price is CHF58.1 and Basilea Pharmaceutica’s (BSLN) 200-day simple moving average is 49.64, creating a Buy signal.

Basilea Pharmaceutica (BSLN) Technical Indicators

Feb 14, 2026, 12:38 PM
Name
Value
Implied Action
RSI (14)
60.46
Neutral
STOCH (9,6)
81.55
Sell
STOCHRSI (14)
81.69
Sell
MACD (12,26)
1.17
Sell
ADX (14)
19.29
Buy
Williams %R
-19.64
Sell
CCI (14)
116.19
Sell
ATR (14)
1.62
-
Ultimate Oscillator
55.39
Neutral
ROC
3.75
Buy
Basilea Pharmaceutica’s (BSLN) Relative Strength Index (RSI) is 60.46, creating a Neutral signal.
Basilea Pharmaceutica’s (BSLN) Trend Strength Indicator (ADX) is 19.29, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) Commodity Channel Index (CCI) is 116.19, creating a Sell signal.
Basilea Pharmaceutica’s (BSLN) Price Rate of Change (ROC) is 3.75, creating a Buy signal.

FAQ

Is BSLN a Buy, Hold, or Sell?
Based on BSLN’s technical indicators, BSLN is a Buy.
    What is BSLN’s RSI (14)?
    BSLN’s RSI (14) is 60.46, which suggests BSLN is a Neutral.
      What is BSLN’s MACD?
      BSLN’s MACD is 1.17, which suggests BSLN is a Sell.
        What is BSLN’s 5-day moving average?
        BSLN’s 5-day moving average is 57.88, which suggests BSLN is a Buy.
          What is BSLN’s 20-day moving average?
          BSLN 20-day moving average is 55.70, which suggests BSLN is a Buy.
            What is BSLN’s 50-day moving average?
            BSLN’s 50-day moving average is 54.15, which suggests BSLN is a Buy.
              What is BSLN’s 200-day moving average?
              BSLN’s 200-day moving average is 49.64, which suggests BSLN is a Buy.
                What is BSLN’s Williams % R (14)?
                BSLN’s Williams % R (14) is -19.64, which suggests BSLN is a Sell.
                  What is BSLN’s CCI (14)?
                  BSLN’s CCI (14) is 116.19, which suggests BSLN is a Sell.
                    What is the share price of Basilea Pharmaceutica?